Immunodiagnostic Systems Holdings Plc (IDH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2010 | 03-2009 | 03-2008 | 03-2007 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -2,499 | -2,782 | -2,718 | -545 | -291 |
| Other Working Capital | -3,265 | -1,377 | -4,257 | -393 | -228 |
| Other Operating Activity | 15,680 | 9,975 | 4,528 | 2,607 | 1,538 |
| Operating Cash Flow | $9,916 | $5,816 | $-2,447 | $1,669 | $1,019 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,973 | -5,751 | -3,136 | -791 | -291 |
| Net Acquisitions | -213 | -53 | -17,454 | N/A | N/A |
| Other Investing Activity | 259 | 118 | 124 | 19 | 0 |
| Investing Cash Flow | $-6,927 | $-5,686 | $-20,466 | $-772 | $-291 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,405 | 13,728 | N/A | N/A |
| Debt Repayment | -2,447 | -2,613 | -532 | -590 | -196 |
| Common Stock Issued | 816 | 3,005 | 12,002 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -30 |
| Dividend Paid | -436 | -360 | -202 | -133 | N/A |
| Other Financing Activity | -102 | -85 | -69 | -99 | -61 |
| Financing Cash Flow | $-2,169 | $1,352 | $24,927 | $-822 | $-287 |
| Beginning Cash Position | 4,456 | 2,974 | 959 | 885 | -358 |
| End Cash Position | 5,276 | 4,456 | 2,973 | 960 | 169 |
| Net Cash Flow | $820 | $1,482 | $2,014 | $75 | $441 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,916 | 5,816 | -2,447 | 1,669 | 1,019 |
| Capital Expenditure | -6,973 | -5,751 | -3,136 | -791 | -291 |
| Free Cash Flow | 2,943 | 65 | -5,583 | 878 | 728 |